CSIMarket
 


Scynexis Inc   (SCYX)
Other Ticker:  
 
 

SCYX's Income from Cont. Operations Growth by Quarter and Year

Scynexis Inc 's Income from Cont. Operations results by quarter and year




SCYX Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -29.24 -42.71 -14.46
III Quarter September -29.58 -0.61 0.91 -7.94
II Quarter June -13.35 1.66 -6.38 -8.40
I Quarter March -5.45 -4.68 -7.00 -22.91
FY   -48.38 -32.87 -55.18 -53.71



SCYX Income from Cont. Operations third quarter 2022 Y/Y Growth Comment
Scynexis Inc in the third quarter 2022 recorded loss from continued operations of $ -29.58 millions.

According to the results reported in the third quarter 2022, Scynexis Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Scynexis Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




SCYX Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scynexis Inc 's third quarter 2022 Income from Cont. Operations $ -29.58 millions SCYX's Income Statement
Scynexis Inc 's third quarter 2021 Income from Cont. Operations $ -0.61 millions Quarterly SCYX's Income Statement
New: More SCYX's historic Income from Cont. Operations Growth >>


SCYX Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scynexis Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's III. Quarter Q/Q Income from Cont. Operations Comment
III. Quarter 2022 results of -29.58 millions by Scynexis Inc appear even more unfavourable considering the -13.35 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Scynexis Inc achieved highest sequential Income from Cont. Operations growth. While Scynexis Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's III. Quarter Q/Q Income from Cont. Operations Comment
III. Quarter 2022 results of -29.58 millions by Scynexis Inc come out even more unfavourable if you take a look at -13.35 millions loss from continued operations in the second quarter.

Within Major Pharmaceutical Preparations industry Scynexis Inc achieved highest sequential Income from Cont. Operations growth. While Scynexis Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Scynexis Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ -77.62 $ -48.64 $ -33.64 $ -32.87 $ -46.33
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Scynexis Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -78 millions in the Sep 30 2022 period.
The business is worsening as the cumulative loss from continued operations is inflating from $ -48.64 millions in the twelve months ending a quarter before and $ -44.82 millions for the twelve months ending in the quarter Sep 30 2021.

Scynexis Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Scynexis Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -78 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative loss from continued operations is becoming larger from $ -48.64 millions in TTM ending quarter Jun 30 2022 and $ -44.82 millions from the TTM period ending Sep 30 2021 Madeline Thomas mentioned.

Scynexis Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
SCYX's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for SCYX's Competitors
Income from Cont. Operations Growth for Scynexis Inc 's Suppliers
Income from Cont. Operations Growth for SCYX's Customers

You may also want to know
SCYX's Annual Growth Rates SCYX's Profitability Ratios SCYX's Asset Turnover Ratio SCYX's Dividend Growth
SCYX's Roe SCYX's Valuation Ratios SCYX's Financial Strength Ratios SCYX's Dividend Payout Ratio
SCYX's Roa SCYX's Inventory Turnover Ratio SCYX's Growth Rates SCYX's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2022




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com